Featured Articles
-
Cell Retention Technology And Specialized Cell Culture Media
8/11/2025
Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.
-
Simplifying Antibody-Drug Conjugate Payload Synthesis
8/5/2025
ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.
-
Integrating Cutting-Edge Technologies In Cell Bank Manufacturing
7/31/2025
Discover how our adoption of a counterflow centrifuge enhances GMP-compliant cell banking through closed-system automation, precision harvesting, and scalable workflows.
-
Non Animal Origin Squalene For High-Risk Applications
7/21/2025
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
Real-Time Monitoring Of Solvent Clearance By TFF In The ADC Process
6/13/2025
Raman spectroscopy revolutionizes ADC manufacturing by enabling real-time monitoring of solvent clearance. Discover how it enhances process control, ensures regulatory compliance, and supports the production of high-quality therapeutics.
-
Using Next Generation Sequencing To Test Raw Materials
5/13/2025
Explore the use of Next Generation Sequencing (NGS) to proactively screen raw materials in biopharmaceutical manufacturing, which aims to reduce viral contamination risks from animal-derived reagents.
-
Replacement Of Traditional Adventitious Virus Testing
5/13/2025
Explore how molecular-based technologies, including PCR and Next Generation Sequencing, are transforming viral safety testing by offering broader, more effective alternatives to traditional animal-based methods like in vivo assays.
-
Handling Protocols: Key Considerations In The Highly Potent API Market
5/12/2025
Explore the growing role of highly potent active pharmaceutical ingredients in oncology and Antibody-Drug Conjugates to highlight manufacturing challenges, safety protocols, and opportunities for CDMOs.
-
Perfusion Cell Line Development For Intensified Processes
5/5/2025
The biopharmaceutical industry is transforming by shifting to continuous and intensified upstream bioprocesses, which are driven by evolving demands. Discover the key goals and innovations shaping this transition for modern healthcare.
-
Helpful Biosafety Testing Innovations Where And When You Need Them
4/24/2025
Monoclonal antibody manufacturing is advancing to boost efficiency, cut costs, and expand access, driven by innovation, demand, and the rise of biosimilars.